Welcome Guest
Home > Clinical Lymphoma & Myeloma > Volume 7 | Supplement 3

Table of Contents

Volume 7 | Supplement 3

Publication Date: March 2007
  • Abstract Abstract
  • Full Text No Access
  • Full Text Pay-Per View
  • Full Text Full Text
  • Add to Cart Add to Cart


Introduction
Page Number of this Article in the Print Version
S94		 Chronic Myeloid Leukemia: Current Management Challenges
Tariq Mughal
  • Abstract
  • No Access
  • Add to Cart
Contributions
Page Number of this Article in the Print Version
S95-S101		 Optimal Management of Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia in 2007
Tariq Mughal, John M. Goldman
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S102-S104		 Allogeneic Hematopoietic Progenitor Cell Transplantation for the Treatment of Chronic Myelogenous Leukemia in the Era of Tyrosine Kinase Inhibitors: Lessons Learned to Date
Sergio Giralt
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S105-S112		 Emerging Safety Issues with Imatinib and Other Abl Tyrosine Kinase Inhibitors
Ehab Atallah, Hagop Kantarjian, Jorge Cortes
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S113-S119		 Novel Abl Kinase Inhibitors in Chronic Myeloid Leukemia in Blastic Phase and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Ronan Swords, Yesid Alvarado, Francis Giles
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S120-S130		 Bcr-Abl Kinase Domain Mutations and the Unsettled Problem of Bcr-AblT315I: Looking into the Future of Controlling Drug Resistance in Chronic Myeloid Leukemia
Thomas O'Hare, Christopher A. Eide, Michael W. Deininger
  • Abstract
  • No Access
  • Add to Cart